Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales

被引:47
作者
Hopkins, K. L.
Batchelor, M. J.
Liebana, E.
Deheer-Graham, A. P.
Threlfalla, E. J.
机构
[1] Hlth Protect Agcy, Ctr Infect, Lab Enter Pathogens, Salmonella Reference Unit, London NW9 5EQ, England
[2] Vet Labs Agcy, Dept Food & Environm Safety, Weybridge KT15 3NB, Surrey, England
关键词
CTX-M; AmpC; beta-lactamases; Escherichia coli; antimicrobial resistance; ampC promoter;
D O I
10.1016/j.ijantimicag.2006.03.027
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
CTX-M and AmpC genes in human isolates of Escherichia coli, their genetic environment and their host plasmids were examined. Isolates (n = 103) were selected based on resistance (minimum inhibitory concentration (MIC) >= 1 mu g/mL) to ceftriaxone and cefotaxime. Polymerase chain reaction (PCR) and sequencing identified 29 isolates containing bla(CTX-M-15), 1 each of bla(CTX-M-2) (a strain originating from Israel) and bla(CTX-M-40), 20 isolates containing bla(CMY-7), 4 bla(CMY-2) and 1 bla(CMY-21). This is the first study of plasmid-mediated AmpC genes in E. coli in the UK. Eleven cefoxitin-resistant, AmpC PCR-negative isolates had ampC promoter region mutations. All bla(CTX-M-15) and 24 of 25 bla(CMY) genes were associated with an ISEcpl-like element. The bla(CTX-M-2) was located in an orf513-bearing class 1 integron. Plasmid restriction digests suggest transfer of genes between different plasmid backbones. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:180 / 192
页数:13
相关论文
共 43 条
[21]   Novel plasmid-mediated CTX-M-8 subgroup extended-spectrum β-lactamase (CTX-M-40) isolated in the UK [J].
Hopkins, KL ;
Deheer-Graham, A ;
Threlfall, EJ ;
Batchelor, MJ ;
Liebana, E .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (06) :572-575
[22]   AMPC CEPHALOSPORINASE OF ESCHERICHIA-COLI K-12 HAS A DIFFERENT EVOLUTIONARY ORIGIN FROM THAT OF BETA-LACTAMASES OF THE PENICILLINASE TYPE [J].
JAURIN, B ;
GRUNDSTROM, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4897-4901
[23]   PLASMID-MEDIATED PRODUCTION OF CLASS-I (AMPC) BETA-LACTAMASE BY 2 KLEBSIELLA-PNEUMONIAE ISOLATES FROM THE UK [J].
JENKS, PJ ;
HU, YM ;
DANEL, F ;
MEHTAR, S ;
LIVERMORE, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (01) :235-236
[24]  
Lartigue MF, 2004, FEMS MICROBIOL LETT, V234, P201, DOI [10.1016/j.femsle.2004.01.051, 10.1111/j.1574-6968.2004.tb09534.x]
[25]   Characterization of β-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom [J].
Liebana, E ;
Gibbs, M ;
Clouting, C ;
Barker, L ;
Clifton-Hadley, FA ;
Pleydell, E ;
Abdalhamid, B ;
Hanson, ND ;
Martin, L ;
Poppe, C ;
Davies, RH .
MICROBIAL DRUG RESISTANCE, 2004, 10 (01) :1-9
[26]   Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals [J].
Mulvey, MR ;
Bryce, E ;
Boyd, DA ;
Ofner-Agostini, M ;
Land, AM ;
Simor, AE ;
Paton, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :358-365
[27]   Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK [J].
Munday, CJ ;
Whitehead, GM ;
Todd, NJ ;
Campbell, M ;
Hawkey, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) :628-633
[28]  
National Committee for Clinical Laboratory Standards, 1999, M100S9 NCCLS
[29]   Prevalence of β-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark [J].
Olesen, I ;
Hasman, H ;
Aarestrup, FM .
MICROBIAL DRUG RESISTANCE, 2004, 10 (04) :334-340
[30]   CHARACTERIZATION OF THE PLASMID MEDIATED BETA-LACTAMASE BIL-1 [J].
PAYNE, DJ ;
WOODFORD, N ;
AMYES, SGB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (02) :119-127